ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Maine » Internal Medicine

Top Internal Medicine Prescribers in Maine

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
DAVID SCOTTON MD

Internal Medicine

112

$20.5K

38
36 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 24%

$183
Average prescription price

Avg: $69

ELIZABETH WEISS M. D.

Internal Medicine

280

$69.4K

30
15 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

37%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

71%
prescriptions for brand name drugs

Avg: 24%

$248
Average prescription price

Avg: $69

MEAGHAN DALY M.D.

Internal Medicine

390

$38.6K

133
82 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 8%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$99
Average prescription price

Avg: $69

TRACY HAWKINS D.O

Internal Medicine

405

$8,917

215
84 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

28%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

12%
prescriptions for brand name drugs

Avg: 24%

$22
Average prescription price

Avg: $69

RICHARD LEMAY MD

Internal Medicine

437

$22.1K

49
45 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 24%

$51
Average prescription price

Avg: $69

SHULAMITH BONHAM MD

Internal Medicine

449

$32.3K

62
11 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$72
Average prescription price

Avg: $69

JOEL BOTLER MD

Internal Medicine

511

$41K

66
62 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 24%

$80
Average prescription price

Avg: $69

YELENA PATSIORNIK MD

Internal Medicine

584

$211K

87
64 are 65+

15%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 24%

$361
Average prescription price

Avg: $69

OSAMA AZIZ M.D.

Internal Medicine

671

$118K

188
135 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

76%
prescriptions for brand name drugs

Avg: 24%

$176
Average prescription price

Avg: $69

LAUREN DESMARAIS DO

Internal Medicine

675

$30.7K

65
38 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 24%

$45
Average prescription price

Avg: $69

SPYRIDON AKRIVAKIS M.D.

Internal Medicine

770

$44.7K

117
90 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 24%

$58
Average prescription price

Avg: $69

DARLEEN MILLER MD

Internal Medicine

807

$41K

136
126 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 24%

$51
Average prescription price

Avg: $69

TODD STAPLEY D.O.

Internal Medicine

811

$40.5K

145
118 are 65+

12%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$50
Average prescription price

Avg: $69

JON OLDER DO

Internal Medicine

812

$38.5K

127
110 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$47
Average prescription price

Avg: $69

NATHANIEL JAMES M.D.

Internal Medicine

845

$32.3K

54
39 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 24%

$38
Average prescription price

Avg: $69

DONALD WEAVER MD

Internal Medicine

883

$82.5K

147
136 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 24%

$93
Average prescription price

Avg: $69

MAUREEN LEE D.O.

Internal Medicine

962

$40.1K

97
75 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 24%

$42
Average prescription price

Avg: $69

DONALD WARE M.D.

Internal Medicine

982

$55.5K

73
69 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 24%

$56
Average prescription price

Avg: $69

DANIEL WOOD MD

Internal Medicine

1,039

$86.6K

154
139 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$83
Average prescription price

Avg: $69

ANDREA KLAYMAN M.D.

Internal Medicine

1,080

$65.1K

92
70 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$60
Average prescription price

Avg: $69

GREGG RAYMOND M.D.

Internal Medicine

1,091

$53.9K

78
42 are 65+

15%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$49
Average prescription price

Avg: $69

ARTHUR SCOTT MD

Internal Medicine

1,141

$55.4K

54
54 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$49
Average prescription price

Avg: $69

JOHN DEVLIN MD

Internal Medicine

1,171

$283K

223
131 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

53%
prescriptions for brand name drugs

Avg: 24%

$242
Average prescription price

Avg: $69

LINDA TYER M.D.

Internal Medicine

1,203

$396K

162
109 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

57%
prescriptions for brand name drugs

Avg: 24%

$329
Average prescription price

Avg: $69

CLAUDE BOMA M.D.

Internal Medicine

1,230

$37.7K

181
136 are 65+

14%
patients receiving schedule two controlled substances

Avg: 7%

6%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 24%

$31
Average prescription price

Avg: $69

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank